DIPNA PHARMACHEM LIMITED

DPL

Small Cap | Pharmaceuticals
12.71
-0.98 (-7.15%)

Stock price as on 06 Feb 2026 at 15:30 PM

Dipna pharmachem limited share price update

As of the latest trading session, Dipna Pharmachem Limited share price is currently at ₹12.71, which is down by ₹-0.98 from its previous closing. Toda...

Dipna Pharmachem Limited stock performance

Today’s low

₹12.66

Today’s high

₹15

₹12.71

52 week low

₹11.23

52 week high

₹26.31

₹12.71
Open
₹15.00
Previous close
₹13.70
Share volume
66,000
Total traded value (Lakh)
₹8.58
Upper circuit
₹16.44
Lower circuit
₹10.96

Dipna Pharmachem Limited fundamentals

Market cap (Cr)
₹33.40
P/E ratio (TTM)
34.35
Book value per share
₹15.75
Beta
0.57
Return on equity
2.55%
Earnings per share (TTM)
₹0.37
Dividend yield
0%
Net profit/quarter (Cr)
₹0.00

Dipna Pharmachem Limited financials

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹124.92

Operating expense

₹123.50

Net income

₹0.97

Net profit margin

0.77%

Earning per share

₹0.41

EBITDA

₹3.44

Effective tax rate

31.69%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹164.34

Operating expense

₹162.93

Net income

₹1.09

Net profit margin

0.66%

Earning per share

₹0.90

EBITDA

₹3.44

Effective tax rate

23.23%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹99.93

Operating expense

₹98.55

Net income

₹0.91

Net profit margin

0.91%

Earning per share

₹0.76

EBITDA

₹2.34

Effective tax rate

34.05%

Particulars

Mar 22 (₹ value in crores)

Revenue

₹72.76

Operating expense

₹71.19

Net income

₹1.17

Net profit margin

1.6%

Earning per share

₹333.39

EBITDA

₹2.21

Effective tax rate

26.11%

Particulars

Mar 21 (₹ value in crores)

Revenue

₹31.00

Operating expense

₹30.96

Net income

₹0.02

Net profit margin

0.06%

Earning per share

₹6.91

EBITDA

₹0.42

Effective tax rate

50%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹16.01

Return on Equity (ROE)

2.55%

Return on Capital Employed (ROCE)

6.64%

Total debt to equity ratio

0.48

EBITDA margin

3%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹15.60

Return on Equity (ROE)

3.52%

Return on Capital Employed (ROCE)

7.05%

Total debt to equity ratio

0.57

EBITDA margin

2.1%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹20.35

Return on Equity (ROE)

6.97%

Return on Capital Employed (ROCE)

9%

Total debt to equity ratio

1

EBITDA margin

2.36%

Particulars (annual)

Mar 22 (₹ value in crores)

Book value per share

₹496.73

Return on Equity (ROE)

100.86%

Return on Capital Employed (ROCE)

17.56%

Total debt to equity ratio

9.75

EBITDA margin

3.01%

Particulars (annual)

Mar 21 (₹ value in crores)

Book value per share

₹163.34

Return on Equity (ROE)

3.54%

Return on Capital Employed (ROCE)

3.46%

Total debt to equity ratio

19.47

EBITDA margin

1.32%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹0.42

Total assets

₹132.37

Total liabilities

₹132.37

Total equity

₹38.49

Shares outstanding

₹2.40

Price to book ratio

₹0.89

Return on assets (%)

0.73%

Return on capital

1.75%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹13.87

Total assets

₹132.90

Total liabilities

₹132.90

Total equity

₹37.51

Shares outstanding

₹2.40

Price to book ratio

₹0.60

Return on assets (%)

0.81%

Return on capital

1.91%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹5.69

Total assets

₹77.55

Total liabilities

₹77.55

Total equity

₹24.35

Shares outstanding

₹1.19

Price to book ratio

₹0.62

Return on assets (%)

1.17%

Return on capital

2.26%

Particulars

Mar 22 (₹ value in crores)

Cash and short term investments

₹0.20

Total assets

₹36.22

Total liabilities

₹36.22

Total equity

₹1.73

Shares outstanding

-

Price to book ratio

-

Return on assets (%)

3.22%

Return on capital

9.78%

Particulars

Mar 21 (₹ value in crores)

Cash and short term investments

₹0.25

Total assets

₹24.79

Total liabilities

₹24.79

Total equity

₹0.57

Shares outstanding

-

Price to book ratio

-

Return on assets (%)

0.09%

Return on capital

0.19%

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹1.42

Cash from operations

-₹8.74

Cash from investing

-₹0.02

Cash from financing

-₹4.23

Net change in cash

-₹13.45

Free cash flow

-₹8.72

Particulars

Mar 24 (₹ value in crores)

Net income

₹1.41

Cash from operations

-₹5.08

Cash from investing

-₹0.01

Cash from financing

₹13.61

Net change in cash

₹8.18

Free cash flow

-₹5.06

Particulars

Mar 23 (₹ value in crores)

Net income

₹1.38

Cash from operations

-₹20.50

Cash from investing

-₹0.01

Cash from financing

₹26.47

Net change in cash

₹5.48

Free cash flow

-₹20.49

Particulars

Mar 22 (₹ value in crores)

Net income

₹1.57

Cash from operations

₹3.21

Cash from investing

-

Cash from financing

-₹2.84

Net change in cash

-₹0.04

Free cash flow

₹3.21

Particulars

Mar 21 (₹ value in crores)

Net income

₹0.05

Cash from operations

-₹2.41

Cash from investing

-

Cash from financing

₹2.50

Net change in cash

₹0.07

Free cash flow

-₹2.40

Dipna Pharmachem Limited technical summary

₹12.71
-7.22 ▼
0
Bearish
16
Bullish
5 Day13.3
10 Day13.4
12 Day13.5
20 Day13.8
26 Day14.1
50 Day15.2
100 Day16.8
200 Day17.3
5 Day13.6
10 Day13.1
12 Day13.1
20 Day13.7
26 Day14.3
50 Day15
100 Day17.8
200 Day19.7

13.5

PIVOT

First support
₹13.30
First resistance
₹13.90
Second support
₹12.90
Second resistance
₹14.10
Third support
₹12.70
Third resistance
₹14.50
RSI
44.11
ADX
15.03
MACD
-0.61
Williams % R
-74.35
Commodity Channel Index (CCI)
-20.17
Date
06 Feb 2026
Same day
48,000
Week
25,800
Month
19,857
1 year
0.57
3 years
0.67
Over 1 month
-12.94%
Over 1 year
-20.06%
Over 3 months
-33.66%
Over 3 years
-4.2%
Over 6 months
-40.66%
Over 6 years
0%

Investment Returns

Over 1 Month12.94%
Over 3 Months33.66%
Over 6 Months40.66%
Over 1 Year20.06%

Dipna Pharmachem Limited Shareholding pattern


Public
90.87%
Promoter holdings
9.12%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Keyur Dipakkumar Shah

23,97,000 (9.12%)

Shareholding of Promoter and Promoter Group

Kajal Ashok Jain

11,24,000 (4.28%)

Public Shareholding

Ashok Dilipkumar Jain

11,20,000 (4.26%)

Public Shareholding

Namita Hemant Jain

11,01,000 (4.19%)

Public Shareholding

Teena Kirti Jain

9,87,000 (3.75%)

Public Shareholding

Promoter sharesShareCategory
Keyur Dipakkumar Shah23,97,000 (9.12%)Shareholding of Promoter and Promoter Group
Kajal Ashok Jain11,24,000 (4.28%)Public Shareholding
Ashok Dilipkumar Jain11,20,000 (4.26%)Public Shareholding
Namita Hemant Jain11,01,000 (4.19%)Public Shareholding
Teena Kirti Jain9,87,000 (3.75%)Public Shareholding
Hemant Naresh Jain Huf7,89,000 (3%)Public Shareholding
Sanjay Nirmal Jain Huf6,57,000 (2.5%)Public Shareholding
Jay Poddar6,51,000 (2.48%)Public Shareholding
Neerita Sanjay Jain5,85,000 (2.23%)Public Shareholding
Maheshbhai Jivanbhai Ramani5,76,000 (2.19%)Public Shareholding
Girish Ganesh Sathe5,10,000 (1.94%)Public Shareholding
Sunita Santosh Goenka4,82,250 (1.83%)Public Shareholding
Siddharth Poddar4,29,000 (1.63%)Public Shareholding
Janhavi Santosh Ghadge3,90,000 (1.48%)Public Shareholding
Vibha R Tripathi3,54,000 (1.35%)Public Shareholding
Ravi Bhushan Puri3,00,000 (1.14%)Public Shareholding
Sahib Puniani2,91,000 (1.11%)Public Shareholding
Nareshkumar Kapoorchand Jain2,91,000 (1.11%)Public Shareholding
Viha Ashok Jain2,76,000 (1.05%)Public Shareholding
Alka Jaysing Tambe2,73,000 (1.04%)Public Shareholding
Dipna Keyur Shah2,500 (0.01%)Shareholding of Promoter and Promoter Group
Chaitanya Chinubhai Nanavati100 (0%)Shareholding of Promoter and Promoter Group
Dhara Nrupeshbhai Shah100 (0%)Shareholding of Promoter and Promoter Group

About DIPNA PHARMACHEM LIMITED

Dipan Pharmachem Limited was incorporated on July 19, 2011. Subsequently, the Company name was changed to 'Dipna Pharmachem Private Limited' on March 29, 2012. Later on, it was converted from Private Limited to Public Limited and the name of Company was changed to 'Dipna Pharmachem Limited' vide fresh Certificate of Incorporation issued by Registrar of Companies, Ahmedabad dated May 25, 2022. Dipna Pharmachem Limited is a trader, importer, and exporter in industrial Chemical and Pharmaceutical Raw materials, APIs, solvents, and Formulation

Parent Organisation

Indian Private

NSE Symbol

DIPNA PHARMACHEM LIMITED

Founded

2011

DIPNA PHARMACHEM LIMITED CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)